Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of var…
Biotechnology
US, Fort Lee [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Nuvectis Pharma, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDNuvectis Pharma, Inc. can't present revenue by segment